FDA inspection
HemaCare Corp: FDA inspection ending Jun 30, 2010
FDA inspection 669934 · No Action Indicated (NAI) · Los Angeles, CA
Key facts
| Inspection ID | 669934 |
|---|---|
| Firm | HemaCare Corp |
| FEI number | 3007895904 |
| Address | 3347 S Hoover St, Bldg C, Ste C10 |
| City | Los Angeles |
| State | CA |
| ZIP | 90007 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Jun 30, 2010 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data